2026-01-18 - Analysis Report
**Amgen Inc Stock Analysis Report**
=====================================

### Company Overview
Amgen Inc is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines for serious medical conditions.

**Return Rate Comparison**
-------------------------

|  | Rate | Rate_vs | Divergence |
| --- | --- | --- | --- |
| Cumulative Return AMGN | 71.01% | 93.36% | -22.35% |

Note: The divergence is calculated as the difference in cumulative return between Amgen and the S&P 500 (VOO) on the last day of the data.

### Alpha, Beta Analysis
-------------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| ---::|------|------|-------|------|-------|
| 2016-2018 | 14.0% | 14.6% | 11.0% | 1.1 | 104.8B |
| 2017-2019 | 41.0% | 12.4% | 24.0% | 0.9 | 129.8B |
| 2018-2020 | 8.0% | 17.7% | -13.0% | 0.8 | 123.8B |
| 2019-2021 | 15.0% | 17.7% | -28.0% | 0.8 | 121.1B |
| 2020-2022 | 15.0% | 15.5% | 17.0% | 0.6 | 141.4B |
| 2021-2023 | 19.0% | 15.3% | 19.0% | 0.4 | 155.1B |
| 2022-2024 | 12.0% | 21.0% | -8.0% | 0.4 | 140.3B |
| 2023-2025 | 38.0% | 21.0% | -24.0% | 0.5 | 176.2B |

### Stock Price Fluctuations
---------------------------

|  | Price |
| --- | --- |
| Close | $330.41 |
| Last-Market | $330.41 |
| 5-day SMA | $327.85 |
| 20-day SMA | $329.14 |
| 60-day SMA | $324.51 |

### RSI, PPO Index Indicators
-----------------------------

|  | Value |
| --- | --- |
| RSI | 47.80 |
| PPO | -0.04 |
| MRI | 0.80 |
| Expected Return | -2.10% |

### News & Significant Events
-----------------------------

* [2026-01-17] Amgen Inc. $AMGN Stock Position Cut by QRG Capital Management Inc. - MarketBeat
* [2026-01-14] Amgen Inc. (NASDAQ:AMGN) Shares Could Be 49% Below Their Intrinsic Value Estimate - Yahoo Finance
* [2026-01-13] Amgen Stock (AMGN) Falls despite Obesity Drug Update — Here’s Wall Street’s Take - TipRanks
* [2026-01-13] BofA Securities raises Amgen stock price target to $304 on valuation shift - Investing.com

**Analyst Opinions**
--------------------

* 27 Opinions
* Mean (1=StrongBuy~5=Sell): 2.34 (~Buy)
* Target Price (avg/high/low): 331.59 / 425.00 / 180.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| ---:|---:|:---:|
| 2025-11-05 | 5.98 | 9.56 B$ |
| 2025-08-06 | 2.66 | 9.18 B$ |
| 2025-05-02 | 3.22 | 8.15 B$ |
| 2024-10-31 | 5.27 | 8.50 B$ |
| 2025-11-05 | 5.27 | 8.50 B$ |

**Financial Information**
---------------------

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $9.56B | 67.75% |
| 2025-06-30 | $9.18B | 67.20% |
| 2025-03-31 | $8.15B | 63.58% |
| 2024-12-31 | $9.09B | 65.75% |
| 2024-09-30 | $8.50B | 61.07% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $9.62B | 33.43% |
| 2025-06-30 | $7.43B | 19.28% |
| 2025-03-31 | $6.21B | 27.87% |
| 2024-12-31 | $5.88B | 10.67% |
| 2024-09-30 | $7.53B | 37.60% |

### Comprehensive Analysis
---------------------------

Amgen Inc has a relatively lower cumulative return compared to the S&P 500 (VOO), with a divergence of -22.35%. The company's Alpha and Beta analysis show varying results over the years, with CAGR ranging from 8% to 41%. The stock price fluctuations indicate a moderate price range, with a 5-day SMA of $327.85 and a 20-day SMA of $329.14. The RSI and PPO index indicators suggest a neutral to bearish market, while the MRI indicates a low-risk investment. The analyst opinions suggest a buy rating with an average target price of $331.59. The recent earnings analysis shows increasing EPS and revenue, but with varying profit margins. The financial information indicates a healthy revenue and profitability, with an ROE ranging from 10.67% to 37.60%. Overall, the comprehensive analysis indicates a moderate to high-risk investment.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.